STOCK TITAN

Lixte Biotechnology Holdings, Inc. (LIXT) Net Income by Year

LIXT

Lixte Biotechnology Holdings, Inc. reported a net loss of $6.1M in fiscal year 2025. This represents a decrease of 69.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Lixte Biotechnology Holdings, Inc. has filed alongside them.

FY2025 annual
Net Income -$6.1M
YoY -69.5%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LIXT Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Net Income-$6.1M-69.5%-$3.6M+29.5%-$5.1M+19.4%-$6.3M+6.2%-$6.7M-106.1%-$3.3M-33.8%-$2.4M-14.4%-$2.1M-18.0%-$1.8M+15.3%-$2.1M+25.2%-$2.9MN/A-$1.4M+61.6%-$3.6M-73.1%-$2.1M

LIXT Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-KQ4'2510-KQ3'2510-QQ2'2510-QQ1'25Q4'2410-KQ3'2410-QQ2'2410-QQ1'24Q4'23Q3'23Q2'23
Net Income-$2.0M-180.1%N/A-$2.0M-100.8%-$776K+23.3%-$710K+26.9%N/A-$986K+3.2%-$1.0M+39.4%-$971K+29.0%N/A-$1.0M+31.1%-$1.7M-7.9%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Lixte Biotechnology Holdings, Inc. financials

Frequently Asked Questions

What was Lixte Biotechnology Holdings, Inc.'s net income in fiscal year 2025?

Lixte Biotechnology Holdings, Inc. reported a net loss of $6.1M in fiscal year 2025.

How fast is Lixte Biotechnology Holdings, Inc.'s net income growing?

Lixte Biotechnology Holdings, Inc. (LIXT) net income fell by 69.5% year over year, from -$3.6M to -$6.1M in fiscal year 2025.

How has Lixte Biotechnology Holdings, Inc.'s net income changed over the years?

Across the 15 fiscal years this page covers, Lixte Biotechnology Holdings, Inc. (LIXT) net income went from -$2.1M in fiscal year 2011 to -$6.1M in fiscal year 2025.

Lixte Biotechnology Holdings, Inc. (LIXT) reported -$2.0M in net income in Q1 2026. This represents a decrease of 180.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Lixte Biotechnology Holdings, Inc. (LIXT) reported on that line in every period on record.